logo-large
  • Browse Categories

Publications by authors named "Jeffrey Emack"

Claim this Profile
S
Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer.
Adi Kartolo, Ryan Holstead, Sidra Khalid, Jeffrey Emack, Wilma Hopman

J Immunother· January 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.
Sidra Khalid, Bassam Mohammed Basulaiman, Jeffrey Emack, Christopher M Booth, Ignacio Duran

Eur Urol Open Sci· October 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy.
Adi Kartolo, Ryan Holstead, Sidra Khalid, Jeffrey Emack, Wilma Hopman

Immunotherapy· August 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring How the New Entrustable Professional Activity Assessment Tools Affect the Quality of Feedback Given to Medical Oncology Residents.
Anna Tomiak, Heather Braund, Rylan Egan, Nancy Dalgarno, Jeffrey Emack

J Cancer Educ· February 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: